NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Exwannabe,

You wrote:

Sawston construction is delayed. Given that it takes time to certify after construction, operation is a ways out. Only $62K of equipment purchases in Q1.

Do you mean the Phase 1 of the new facility in Sawston? The ATMP manufacturing facility with two completed suites (185m2 i.a. each) comprising B, C and PD/QC labs, offices and storage space?
The Sawston site that is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA?

MAY 2020.
Advent Bioservices is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA for the Sawston site.

https://www.sciencedirect.com/science/article/pii/S1465324920303959

Or do you mean the next phase of buildout of the Sawston facility? The facility that is currently being fitted out with a third ‘cleanroom' suite? The one with the double shifts?

On March 26, 2020, the Company entered into a Loan Agreement (the “Loan Agreement”) with Cambridge & Peterborough Combined Authority (the “Lender”) for a loan of £1.35 million (approximately $1.7 million) (the “Loan”) for the next phase of buildout of the Sawston facility.
https://www.sec.gov/Archives/edgar/data/1072379/000110465920076154/tm2014603-1_10q.htm

In addition, manufacturing of DCVax products is impeded by personnel being under lockdown, and the buildout of the Sawston facility has been delayed by the construction sector shutdown and restrictions. The Company anticipates that such effects of the COVID-19 situation may continue for an extended period of time. However, the Company is exploring possible ways of mitigating these effects, such as employing double shifts for some of the Sawston facility buildout.
https://www.sec.gov/Archives/edgar/data/1072379/000110465920076154/tm2014603-1_10q.htm